Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC protocol 18781)

Authors:
  • EMEgon Macher
    Egon Macher
  • SSStefan Suciu
    Stefan Suciu
  • DTDenis Thomas
    Denis Thomas
  • PSPeter A. Steerenberg
    Peter A. Steerenberg
  • PRPhilip Rümke
    Philip Rümke

Abstract
No abstract available

This publication has 15 references indexed in Scilit: